Among the industry-sponsored clinical trials initiated in Q1 2017, oncology trials dominated the field, followed by clinical trials for CNS.
Figure 1: oncology dominates industry-sponsored clinical trials in Q1 2017
Go deeper with GlobalData
Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]
Among these studies, there are more Phase I (241) studies than Phase II (234) and Phase III (193), accounting for 29%, 28% and 23% of the total clinical trials, respectively.
Figure 2: industry-sponsored clinical trials initiated in Q1 2017 by phase
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]
Abbvie started the most clinical trials, followed by GSK in second place.
Figure 3: top sponsors for industry-sponsored clinical trials initiated in Q1 2017
Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]
